For the quarter ending 2025-09-30, DROR had $175,881 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -653,528 | -1,335,461 |
| Stock-based compensation expense | 0 | 39,170 |
| Depreciation | 1,255 | 2,450 |
| Amortization of debt discount | 159,813 | 14,595 |
| Change in fair value of derivative liability | 7,438 | -1,903 |
| Receivables and prepaid expenses | -36,024 | -42,696 |
| Accounts payable | 41,391 | 190,500 |
| Accrued expenses and other payables | -27,406 | 29,311 |
| Accrued severance | -10,894 | -33,679 |
| Net cash used in operating activities | -424,119 | -984,963 |
| Purchase of property and equipment | - | 0 |
| Net cash used in investing activities | - | 0 |
| Proceeds from loans | - | 500,000 |
| Proceeds from convertible promissory notes, net | 1,100,000 | - |
| Net cash provided by financing activities | 600,000 | 500,000 |
| Net decrease in cash | 175,881 | -484,963 |
| Cash and cash equivalents at beginning of period | 549,444 | - |
| Cash and cash equivalents at end of period | 240,362 | - |
Dror Ortho-Design, Inc. (DROR)
Dror Ortho-Design, Inc. (DROR)